INMB
Price:
$6.25
Market Cap:
$138.58M
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsb...[Read more]
Industry
Biotechnology
IPO Date
2019-02-04
Stock Exchange
NASDAQ
Ticker
INMB
According to INmune Bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.59. This represents a change of 17.57% compared to the average of 2.21 of the last 4 quarters.
The mean historical Current Ratio of INmune Bio, Inc. over the last ten years is 6.66. The current 2.59 Current Ratio has changed 3.79% with respect to the historical average. Over the past ten years (40 quarters), INMB's Current Ratio was at its highest in in the June 2022 quarter at 30.87. The Current Ratio was at its lowest in in the September 2016 quarter at 0.
Average
6.66
Median
5.92
Minimum
0.39
Maximum
18.95
Discovering the peaks and valleys of INmune Bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 975.27%
Maximum Annual Current Ratio = 18.95
Minimum Annual Increase = -83.19%
Minimum Annual Current Ratio = 0.39
Year | Current Ratio | Change |
---|---|---|
2023 | 2.16 | -63.48% |
2022 | 5.92 | -68.74% |
2021 | 18.95 | 40.34% |
2020 | 13.50 | 21.80% |
2019 | 11.09 | 975.27% |
2018 | 1.03 | -83.19% |
2017 | 6.13 | 715.91% |
2016 | 0.75 | 94.53% |
The current Current Ratio of INmune Bio, Inc. (INMB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.01
5-year avg
10.33
10-year avg
6.66
INmune Bio, Inc.’s Current Ratio is greater than TFF Pharmaceuticals, Inc. (1.63), less than Anebulo Pharmaceuticals, Inc. (13.46), greater than Abcam plc (1.35), less than AN2 Therapeutics, Inc. (10.61), greater than Cue Biopharma, Inc. (2.06), less than Anixa Biosciences, Inc. (11.31), less than IN8bio, Inc. (2.66), greater than PolyPid Ltd. (0.95), less than Aerovate Therapeutics, Inc. (6.51), less than Eliem Therapeutics, Inc. (60.41), less than Decibel Therapeutics, Inc. (3.03), less than Anavex Life Sciences Corp. (12.04), less than Cassava Sciences, Inc. (4.07), greater than BioVie Inc. (2.57), less than Cognition Therapeutics, Inc. (3.07), less than TScan Therapeutics, Inc. (7.77), less than Dermata Therapeutics, Inc. (2.73),
Company | Current Ratio | Market cap |
---|---|---|
1.63 | $6.59M | |
13.46 | $49.01M | |
1.35 | $5.52B | |
10.61 | $32.23M | |
2.06 | $89.71M | |
11.31 | $111.02M | |
2.66 | $14.26M | |
0.95 | $22.66M | |
6.51 | $78.52M | |
60.41 | $342.68M | |
3.03 | $123.37M | |
12.04 | $619.01M | |
4.07 | $1.24B | |
2.57 | $44.57M | |
3.07 | $19.04M | |
7.77 | $268.04M | |
2.73 | $1.84M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like INmune Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like INmune Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is INmune Bio, Inc.'s Current Ratio?
How is the Current Ratio calculated for INmune Bio, Inc. (INMB)?
What is the highest Current Ratio for INmune Bio, Inc. (INMB)?
What is the 3-year average Current Ratio for INmune Bio, Inc. (INMB)?
What is the 5-year average Current Ratio for INmune Bio, Inc. (INMB)?
How does the current Current Ratio for INmune Bio, Inc. (INMB) compare to its historical average?